EichorEICHOR
Condition: Bipolar Disorder Mixed Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Bipolar Disorder Mixed

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · 174 location(s) · Bristol-Myers Squibb · NCT06929273Chinese Longitudinal and Systematic Study of Bioplar Disorder
NA · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT05480150Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
Phase 2 · 22 location(s) · Rapport Therapeutics Inc. · NCT07046494An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Ma
Phase 2 · 9 location(s) · Neurocrine Biosciences · NCT07288320A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Featur
Phase 3 · 104 location(s) · Bristol-Myers Squibb · NCT07140913A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2
Phase 3 · 85 location(s) · Bristol-Myers Squibb · NCT06951711A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
Phase 3 · 73 location(s) · Bristol-Myers Squibb · NCT06951698
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.